Search Results - "Skov, Birgit G"

The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group by Thunnissen, Erik, Kerr, Keith M, Herth, Felix J.F, Lantuejoul, Sylvie, Papotti, Mauro, Rintoul, Robert C, Rossi, Giulio, Skov, Birgit G, Weynand, Birgit, Bubendorf, Lukas, Katrien, Grünberg, Johansson, Leif, López-Ríos, Fernando, Ninane, Vincent, Olszewski, Włodzimierz, Popper, Helmut, Jaume, Sauleda, Schnabel, Philipp, Thiberville, Luc, Laenger, Florian

“…Highlights ► The diagnosis of lung cancer involves the identification and complete classification of malignancy. ► New therapeutic options require specific…”
Get full text

Paired Comparison of PD-L1 Expression on Cytologic and Histologic Specimens From Malignancies in the Lung Assessed With PD-L1 IHC 28-8pharmDx and PD-L1 IHC 22C3pharmDx by Skov, Birgit G, Skov, Torsten

“…Programmed cell death ligand-1 (PD-L1) expression is a predictive biomarker for anti-PD-1 immunotherapy in non-small cell lung cancer. Different…”
Get full text

Comparison of PD-L1 Expression Using 2 Validated PD-L1 IHC 22C3 pharmDx Methods in Non–Small Cell Lung Cancer in a Routine Hospital Setting by Skov, Birgit G.

“…Concordance between 3 validated, commercial programmed cell death ligand 1 (PD-L1) assays and their associated platforms (PD-L1 IHC 22C3 pharmDx Autostainer…”
Get full text

Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling by Wille, Mathilde M W, Dirksen, Asger, Ashraf, Haseem, Saghir, Zaigham, Bach, Karen S, Brodersen, John, Clementsen, Paul F, Hansen, Hanne, Larsen, Klaus R, Mortensen, Jann, Rasmussen, Jakob F, Seersholm, Niels, Skov, Birgit G, Thomsen, Laura H, Tønnesen, Philip, Pedersen, Jesper H

“…As of April 2015, participants in the Danish Lung Cancer Screening Trial had been followed for at least 5 years since their last screening. Mortality, causes…”
Get full text

Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab by Rohrberg, Kristoffer Staal, Pappot, Helle, Lassen, Ulrik, Westman, Maj, Olesen, René K., Pfeiffer, Per, Ladekarl, Morten, Sørensen, Morten, Christensen, Ib J., Skov, Birgit G.

“…Malignancies in the upper gastrointestinal (UGI) tract are amongst the most aggressive cancers and only few treatment options exist. We have recently analysed…”
Get full text

The prevalence of EGFR mutations in non-small cell lung cancer in an unselected Caucasian population by Skov, Birgit G, Høgdall, Estrid, Clementsen, Paul, Krasnik, Mark, Larsen, Klaus Richter, Sørensen, Jens Benn, Skov, Torsten, Mellemgaard, Anders

“…EGFR mutation frequencies in unselected Caucasian populations are unknown. This study assesses the prevalence of EGFR mutations in an unselected…”
Get full text

High specificity but low sensitivity of mutation-specific antibodies against EGFR mutations in non-small-cell lung cancer by Bondgaard, Anna-Louise, Høgdall, Estrid, Mellemgaard, Anders, Skov, Birgit G

“…Determination of epidermal growth factor receptor (EGFR) mutations has a pivotal impact on treatment of non-small-cell lung cancer (NSCLC). A standardized test…”
Get full text

The prevalence of ALK rearrangement in pulmonary adenocarcinomas in an unselected Caucasian population from a defined catchment area: impact of smoking by Skov, Birgit G, Clementsen, Paul, Larsen, Klaus R, Sørensen, Jens B, Mellemgaard, Anders

“…Aims To assess the prevalence of EML4–ALK rearrangement gene measured by immunohistochemistry in an unselected population‐based consecutive cohort of patients…”
Get full text

Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial by Fischer, Barbara M, Mortensen, Jann, Hansen, Hanne, Vilmann, Peter, Larsen, Søren S, Loft, Annika, Bertelsen, Anne K, Ravn, Jesper, Clementsen, Paul, Høegholm, Asbjørn, Larsen, Klaus R, Dirksen, Asger, Skov, Birgit G, Krasnik, Mark, Højgaard, Liselotte, Lassen, Ulrik

“…Correct mediastinal staging is a cornerstone in the treatment of patients with non-small cell lung cancer. A large range of methods is available for this…”
Get more information

Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer by Hansen, Line V, Skov, Birgit G, Ploug, Michael, Pappot, Helle

“…Summary Purpose C4.4A expression has been implicated in human cancer progression. This protein is a structural homologue of the urokinase receptor, uPAR, which…”
Get full text

Endobronchial ultrasound-guided biopsy performed under optimal conditions in patients with known or suspected lung cancer may render mediastinoscopy unnecessary by Clementsen, Paul F, Skov, Birgit G, Vilmann, Peter, Krasnik, Mark

“…Mediastinoscopy is the gold standard for preoperative mediastinal staging of patients with suspected or proven lung cancer. Since the development of endoscopic…”
Get full text

Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report by Rossing, Henrik H, Grauslund, Morten, Urbanska, Edyta M, Melchior, Linea C, Rask, Charlotte K, Costa, Junia C, Skov, Birgit G, Sørensen, Jens Benn, Santoni-Rugiu, Eric

“…Anaplastic lymphoma kinase-positive non-small cell lung carcinoma patients are generally highly responsive to the dual anaplastic lymphoma kinase and MET…”
Get full text

Endoscopic ultrasound guided biopsy versus mediastinoscopy for analysis of paratracheal and subcarinal lymph nodes in lung cancer staging by Larsen, Soeren S., Vilmann, Peter, Krasnik, Mark, Dirksen, Asger, Clementsen, Paul, Skov, Birgit G., Jacobsen, Grete Krag

“…Exact mediastinal evaluation of patients with non-small-cell lung cancer (NSCLC) is mandatory to improve selection of resectable and curable patients for…”
Get full text

Endoscopic ultrasound guided biopsy performed routinely in lung cancer staging spares futile thoracotomies: Preliminary results from a randomised clinical trial by Larsen, Soeren S., Vilmann, Peter, Krasnik, Mark, Dirksen, Asger, Clementsen, Paul, Maltbaek, Niels, Lassen, Ulrik, Skov, Birgit G., Jacobsen, Grete Krag

“…Up to 45% of operations with curative intent for non-small-cell lung cancer (NSCLC) can be regarded as futile, apparently because the stage of the disease is…”
Get full text

Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers by Rohrberg, Kristoffer S, Olesen, René K, Pfeiffer, Per, Ladekarl, Morten, Pappot, Helle, Christensen, Ib J, Høyer-Hansen, Gunilla, Sørensen, Morten, Skov, Birgit G, Buysschaert, Ian, Carmeliet, Peter, Lassen, Ulrik

“…Patients with upper gastrointestinal cancers have a poor prognosis and only few treatment options. The epidermal growth factor receptor (EGFR) and vascular…”
Get more information

High Dermal Mast Cell Prevalence is a Predisposing Factor for Basal Cell Carcinoma in Humans by Grimbaldeston, Michele A., Skov, Lone, Baadsgaard, Ole, Skov, Birgit G., Marshman, Gillian, Finlay-Jones, John J., Hart, Prue H.

“…Ultraviolet B radiation (280–320 nm) can initiate skin cancer as well as suppress the immune system, thereby preventing the rejection of ultraviolet-B-induced…”
Get full text

Ground-Glass Opacity Lung Nodules in the Era of Lung Cancer CT Screening: Radiology, Pathology, and Clinical Management by Pedersen, Jesper Holst, Saghir, Zaigham, Wille, Mathilde Marie Winkler, Thomsen, Laura Hohwü, Skov, Birgit Guldhammer, Ashraf, Haseem

“…The advent of computed tomography screening for lung cancer will increase the incidence of ground-glass opacity (GGO) nodules detected and referred for…”
Get more information

A comparison of endoscopic ultrasound guided biopsy and positron emission tomography with integrated computed tomography in lung cancer staging by Larsen, S S, Vilmann, P, Krasnik, K, Dirksen, Asger, Clementsen, P, Skov, Birgit G, Jacobsen, Grete Krag, Lassen, U, Eigtved, Annika, Berthelsen, Anne Kiil, Mortensen, J, Hoejgaard, Liselotte

“…Exact staging of patients with non-small-cell lung cancer (NSCLC) is important to improve selection of resectable and curable patients for surgery. Positron…”
Get full text

Concomitant occurrence of EGFR -positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report by Rossing, Henrik H, Grauslund, Morten, Urbanska, Edyta M, Melchior, Linea C, Rask, Charlotte K, Costa, Junia C, Skov, Birgit G, Sarensen, Jens Benn, Santoni-Rugiu, Eric

“…Anaplastic lymphoma kinase-positive non-small cell lung carcinoma patients are generally highly responsive to the dual anaplastic lymphoma kinase and MET…”
Get full text

Are pathologists biased by clinical information?: A blinded cross-over study of the histopathological diagnosis of mesothelial tumours versus pulmonary adenocarcinoma by Skov, B G, Braendstrup, O, Hirsch, F R, Lauritzen, A F, Nielsen, H W, Skov, T

“…In a blinded cross-over design, we studied whether three pathologists were biased by clinical information when making histopathological diagnoses of…”
Get more information